m+Medelevator.RU
← Поиск публикаций
Wiadomosci lekarskie (Warsaw, Poland : 1960) · 2025

The application of holter monitoring in the diagnosis of atrial fibrillation and its significance in the context of ischemic strokes.

СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Bieńkowski Wojciech Jędrzej, Bieńkowski Michał, Kusy Bartłomiej, Nowakowska Monika, Żerańska Anna, Retman Patrycja, Kucharczyk Piotr, Charkot Julia

Аннотация

OBJECTIVE: Aim: This study aims to evaluate the effectiveness of prolonged Holter monitoring in detecting atrial fibrillation (AF) and other arrhythmias in patients following ischemic stroke. We seek to establish the optimal duration of monitoring that maximizes detection rates while considering clinical feasibility and cost-effectiveness.

PATIENTS AND METHODS: Materials and Methods: We conducted a systematic review of recent literature, analyzing data from randomized clinical trials and observational studies that assessed the yield of AF detection through various durations of Holter monitoring. Key metrics included detection rates of AF and other relevant arrhythmias, along with patient outcomes related to therapeutic interventions initiated based on monitoring results.

CONCLUSION: Conclusions: This review highlights the crucial role of prolonged Holter monitoring, particularly 7-day monitoring, in detecting paroxysmal atrial fibrillation (AF) among ischemic stroke survivors, especially those with cryptogenic strokes. Extended monitoring significantly improves AF detection, enabling timely anticoagulation therapy and better stroke prevention. While challenges like patient compliance and cost-effectiveness remain, integrating prolonged Holter monitoring into standard care could enhance diagnostic accuracy and reduce recurrent stroke risk.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты